News for OncoQuest Pharmaceuticals Inc. (078590.KQ)

OncoQuest Pharmaceuticals Inc. Announces First Patient Enrolled in Each of Two Investigator Initiated Clinical Trials of Oregovomab in Combination Therapy for the Treatment of... | September 2, 2021

TSX Venture: QPT  EDMONTON, AB, July 7, 2021 /CNW/ - Quest PharmaTech Inc. (TSX-V: QPT) ('Quest' or the 'Company') today announced the results of ...

/PRNewswire/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") announces that clinical investigators working with OncoQuest Pharmaceuticals, Inc....

TSX Venture: QPT                                                                      EDMONTON, AB, June 1, 2021 /PRNewswire/ - Quest PharmaTech Inc. (TSXV: